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Abstract: Astaxanthin (3,3′-dihydroxy-β,β-carotene-4,4′-dione), a high-value ketocarotenoid 
with a broad range of applications in food, feed, nutraceutical, and pharmaceutical 
industries, has been gaining great attention from science and the public in recent years. The 
green microalgae Haematococcus pluvialis and Chlorella zofingiensis represent the most 
promising producers of natural astaxanthin. Although H. pluvialis possesses the highest 
intracellular astaxanthin content and is now believed to be a good producer of astaxanthin, 
it has intrinsic shortcomings such as slow growth rate, low biomass yield, and a high light 
requirement. In contrast, C. zofingiensis grows fast phototrophically, heterotrophically and 
mixtrophically, is easy to be cultured and scaled up both indoors and outdoors, and can 
achieve ultrahigh cell densities. These robust biotechnological traits provide C. zofingiensis 
with high potential to be a better organism than H. pluvialis for mass astaxanthin production. 
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This review aims to provide an overview of the biology and industrial potential of  
C. zofingiensis as an alternative astaxanthin producer. The path forward for further 
expansion of the astaxanthin production from C. zofingiensis with respect to both 
challenges and opportunities is also discussed. 
Keywords: astaxanthin; Chlorella zofingiensis; fed-batch; genetic engineering; mass 
cultivation; microalgae; stress 
 
1. Introduction 
Microalgae are sunlight-driven cell factories that are able to efficiently utilize carbon dioxide for the 
production of numerous products such as proteins, polysaccharides, oils, vitamins, carotenoids and 
other biologically active compounds, and are therefore used in a wide variety of technological 
applications for the development of feed and food products [1,2]. Microalgae-based carotenoid 
production has been intensively studied in recent years, e.g., β-carotene from Dunaliella salina [3], 
zeaxanthin from Synechocystis [4], lutein from Chlorella protothecoides [5], and astaxanthin from 
Haematococcus pluvialis and Chlorella zofingiensis [6,7]. Carotenoids represent a group of 
structurally diverse terpenoid pigments with the majority being a 40-carbon chain conjugated by 
double bonds (Figure 1). Of the carotenoids, astaxanthin, a red ketocarotenoid, has the highest value. 
Because of its strong pigmentation function, powerful antioxidative activity and broad beneficial 
effects on human health, astaxanthin possesses a wide range of applications in feed, food, 
nutraceutical, and pharmaceutical industries [8–10]. C. zofingiensis grows fast phototrophically, 
heterotrophically and mixtrophically, is easy to be cultured and scaled up both indoors and outdoors, 
achieves ultrahigh cell density, and is therefore regarded as a potential alternative to H. pluvialis to 
produce astaxanthin [7,11–14]. This article intends to provide an overview of the current status of 
astaxanthin and the potential of using C. zofingiensis for astaxanthin production. The possible 
improvements in production economics are also discussed, including genetic engineering for strain 
optimization, exploration of advanced culture systems and biorefinery-based production strategies. 
Breakthroughs and innovations occurring in these areas will greatly expand the production capacity 
and lower the production cost, driving C. zofingiensis into the high-value market for cost-effective 
production of astaxanthin. 
2. Astaxanthin and Its Applications 
Astaxanthin has a chemical formula of C40H52O4 and a molecular weight of 596.86 in geometric cis 
and trans isomers; the latter is thermodynamically more stable than the former and is found 
predominantly in nature [15]. Trans astaxanthin has three forms of stereoisomers: two enantiomers 
(3R, 3′R and 3S, 3′S) and a meso form (3R, 3′S) [16]. The isomers are identical in molecular and 
structural formula with the only difference in position of the rotating functional group. 3S, 3′S is the 
most abundant isomer in nature, predominantly synthesized by green microalgae [17]. Synthetic 
astaxanthin contains a mixture of isomers (3S, 3′S), (3S, 3′R), and (3R, 3′R) at the ratio of 1:2:1. 
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Astaxanthin is either in free form or esterified on its one or both hydroxyl groups with various fatty 
acids such as palmitic, stearic, and oleic acids. Synthetic astaxanthin is in free form while the natural 
one found in algae is mainly in esterified form. 
Figure 1. Chemical structure of selected carotenoids. 
 
A strong pigmentation allows astaxanthin to serve as a feed supplement for aquaculture. The use of 
astaxanthin in aquaculture species, for example salmon and lobster, has been extensively studied [18–20]. 
Animals cannot synthesize carotenoids de novo but have to obtain carotenoids through their food chain 
or feeds. The dietary carotenoids give such organisms as salmonids and crustaceans the reddish-orange 
color that is regarded by consumers as one of the key quality attributes. Astaxanthin is the major 
carotenoid found in certain marine animals, for example, in crab, the red pigment accounts for more 
than 80% of total carotenoids [21]. Because of the higher color intensity and better absorption by the 
digestive tract of salmonids, astaxanthin is preferred over canthaxanthin in aquatic farming [22].  
In addition to pigmentation, astaxanthin has been demonstrated to benefit the growth and survival of 
larval fish and shrimp [23,24]. Astaxanthin is also used in the tropical marine industry aiming to 
pigment ornamental fish [25].  
Furthermore, astaxanthin possesses potent antioxidant activity, which has been demonstrated in 
numerous studies [26–32]. Astaxanthin is much more effective in scavenging free radicals than other 
carotenoids and Vitamin E [26,27,29]. It is the powerful antioxidative activity that makes astaxanthin 
beneficial to human health, e.g., reducing DNA damage [33], protecting cells of eyes and skin from  
UV-light mediated photo-oxidation [34], attenuating inflammation by quenching ROS [35], boosting 
immune system by enhancing the production of antibodies and increasing the total number of  
T-cells [36,37], and benefiting heart health by modifying blood levels of LDL and HDL cholesterol [38]. 
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3. Sources of Astaxanthin 
Being widely used in aquatic farming as a feed additive, the astaxanthin market in the United States 
is estimated to be US$200 million per year at a price of around US$2,500 per kg. Nowadays, 
commercial astaxanthin for aquaculture is mainly chemically synthesized from petrochemical sources, 
whereas natural astaxanthin contributes only to a minor portion of the market [8]. Although the current 
astaxanthin market is dominated by synthetic products, the growing demand of customers for natural 
foods has urged the production of astaxanthin from natural sources such as crustacean by-products, 
yeast, microalgae and transgenic plants.  
Crustacean by-products such as heads, shells and tails generated from food processing consist 
mainly of chitin, proteins, fatty acids and carotenoids [39]. The carotenoid composition and content in 
crustacean by-products have been well studied [21,40–44], and indicate that there is potential for these 
by-products to be a natural astaxanthin source. However, these by-products generally contain only a 
small amount of astaxanthin but high contents of ash and chitin that significantly decrease the 
digestibility [16], making the use of crustacean by-products in fish feeding less feasible and economical. 
The red yeast Xanthophyllomyces dendrorhous (previously referred as Phaffia rhodozyma) is able 
to accumulate astaxanthin [45–48]. X. dendrorhous can grow fast and achieve high cell density by 
utilizing a variety of carbon sources such as glucose, xylose and even molasses. However, the cellular 
astaxanthin content is relatively low, varying from 0.16 to 1.1 mg·g
−1
 dry weight depending on 
different strains of X. dendrorhous [49]. The astaxanthin content can be enhanced by using genetic 
modification strategies [50], which allowed the isolated mutants of X. dendrorhous to produce  
1.5–3.8-fold more astaxanthin than the wild type cells. Currently, X. dendrorhous is sold commercially 
in a fine powder as a natural source of astaxanthin as fish feed. The thick cell walls of yeast, however, 
hinder the assimilation of astaxanthin by fish and thus cell wall disruption is needed [51]. The  
X. dendrorhous derived astaxanthin is in the 3R, 3′R form which is exceptional among known 
astaxanthin producing organisms [52]. 
With the exception of Adonis annua, which produces astaxanthin in its flower petals [53], higher 
plants are unable to synthesize astaxanthin because they are devoid of the β-carotene ketolase that 
induces keto-moieties to the 4,4′ position of β-ionone rings of β-carotene and zeaxanthin. However, the 
production of astaxanthin can be achieved through the functional expression of a heterologous  
β-carotene ketolase gene in plants. There are numerous studies addressing the accumulation of 
astaxanthin in transgenic plants including tobacco [54–57], Arabidopsis [58], potato [59,60], carrot [61] 
and even tomato [62]. Although astaxanthin is produced in low amounts in transgenic plants, the 
accumulated astaxanthin adds nutritional value to the edible parts of crop plants for human health and 
may reach commercial use in the future.  
Microalgae represent a source with the most potential for natural astaxanthin production and have 
therefore been subjected to thorough investigations in terms of strain screening, culture medium 
optimization, stress induction, cultivation strategy, modification and genetic improvements for 
astaxanthin production [6,7,12,13,63–69]. The ability of H. pluvialis to accumulate astaxanthin up to 
4% of its dry biomass, the highest known content in nature, has led researchers to focus on H. pluvialis 
for commercial astaxanthin production [63]. Haematococcus algal meal has been approved as a color 
additive in salmonid feeds and as a dietary-supplement for human consumption in Japan, USA and 
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some other countries. In large-scale, enclosed photobioreactor or outdoor systems, a two-step process 
is employed for the production of astaxanthin-rich Heamatococcus cells: cell biomass accumulation 
and astaxanthin induction. First, vegetative cells accumulate and achieve a sufficient density under optimal 
growth conditions; the high density culture is then subjected to stress conditions (e.g., deprivation of 
nitrate, high light intensity, and salt stress) for astaxanthin induction [6,70].  
Although H. pluvialis can accumulate a high amount of astaxanthin, it grows relatively slowly with a 
low biomass yield and is susceptible to contamination by other fast-growing organisms [17,64,67,71].  
In addition, extremely high light illumination is required for astaxanthin induction and accumulation in 
this alga thus hindering its commercial application [70,72]. The green alga Chlorella zofingiensis has 
recently been regarded as a potential alternative host for mass production of astaxanthin due to its fast 
growth, low sensitivity to contamination and unfavorable environments, and astaxanthin accumulation 
under heterotrophic conditions with glucose as the sole carbon and energy source [7,11–13,66].  
Despite the many natural sources of astaxanthin, the majority of astaxanthin on the market is 
synthetically derived. The difference between natural and synthetic astaxanthin lies in their 
stereochemical orientation. Synthetic astaxanthin is a mixture of three isomeric forms with 50% being 
3R, 3′S, while natural astaxanthin from microalgae is in the 3S, 3′S form. The 3S, 3′S form of 
astaxanthin is reported to give a stronger pigmentation to rainbow trout than other forms and is 
therefore preferred as a feed additive for fish farming [73]. Haematococcus astaxanthin is thought to 
play important roles in human health and nutrition, while the biological effect of other isomers has not 
been established [8]. Moreover, unlike synthetic astaxanthin that is present in free form, natural 
astaxanthin usually exists mono-esterified or di-esterified with fatty acids [7,74,75]. The esterified 
astaxanthin is inherently more stable than the free form, thus providing a greater shelf life without 
oxidation. As consumers become more and more aware of the putative benefits of natural astaxanthin, 
and as the commercial production is optimized with lowered costs, the natural astaxanthin will beat 
petroleum derived synthetic astaxanthin and finally dominate the market. 
4. Chlorella zofingiensis as a Potential Producer of Astaxanthin 
4.1. Taxonomy  
C. zofingiensis is a fresh water green microalga once assigned to the Genus Chlorella, but some 
reports classify this alga into Genus Muriella [76], Mychonastes [77], or Chromochloris [78], 
indicating an evolutionary distance from the ―true Chlorella‖. C. zofingiensis cells are non-motile and 
in unicellular and spherical form, with the cell size ranging from 2 to 15 μm in diameter (Figure 2). 
Through the formation of autospores, C. zofingiensis asexually reproduces daughter cells from  
non-motile parental cells [79]. The asexual reproduction generally involves three phases: growth, 
ripening, and division [80]. 
Observations using an electron microscope reveal that under favorable culture conditions,  
C. zofingiensis has a cup-shaped chloroplast in which starch is abundant in scattered granules (Figure 3A). 
The chloroplast situates peripherally in the cytoplasm and occupies about half of the cell volume; in 
contrast, the nucleus is somewhat centrally located in the cytoplasm (Figure 3A). Mitochondria appear in 
an ovoid shape and are closely associated with chloroplast (Figure 3A). Lipid bodies are also observed 
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peripherally and can be induced to build up under stress conditions, which may merge together to form a 
thick layer surrounding the shrunken chloroplast which has decreased starch levels (Figure 3B). 
Figure 2. Light micrographs of C. zofingiensis cells under favorable (A) and stress (B) 
conditions. Bars, 5 μm. 
 
Figure 3. The ultrastructure of C. zofingiensis cells under favorable (A) and stress  
(B) conditions. Bars, 0.5 μm;·L, lipid body; N, nucleus; M, mitochondria; P, plastid; S, 
starch granule. 
 
4.2. Pigment Profile 
C. zofingiensis contains chlorophylls a and b for photosynthesis and both primary and secondary 
carotenoids are observed within C. zofingiensis cells. Like plants and other algae, C. zofingiensis 
synthesizes and accumulates primary carotenoids (e.g., β-carotene, lutein and zeaxanthin) in the 
chloroplast [81,82]. In contrast, secondary carotenoids such as astaxanthin, canthaxanthin and 
adonixanthin are found to accumulate in lipid bodies outside the chloroplast [11,81]. The accumulation 
of secondary carotenoids, in general, is considered to be associated with stress conditions, under which 
algal cells are protected against oxidative damage by these anti-oxidative carotenoids through 
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quenching the excessive reactive oxygen species (ROS) and other free radicals [81,83]. For example, 
when growing under high light and nitrogen starvation, C. zofingiensis produces mainly secondary 
carotenoids, of which around 70% is astaxanthin [81]. A general pigment profile of C. zofingiensis 
under astaxanthin-inducing conditions is shown in Figure 4. Astaxanthin in C. zofingiensis occurs 
predominantly in the form of mono- and di-esters. 
Figure 4. A HPLC chromatogram showing a general pigment profile of C. zofingiensis 
under astaxanthin-inducing conditions (four-day induction with 20 g L
−1
 glucose in the 
dark). 1 Neoxanthin; 2 Violaxanthin; 3 Antheraxanthin; 4, 5, 7, 8, 11, 19, 28, 29, 30, 35, 36  
Unknown or degraded lutein and chlorophylls; 6 Astaxanthin; 9, 10 Adonixanthin; 12 Lutein; 
13, 14, 15 Zeaxanthin; 16, 17 Canthaxanthin; 18 Chlorophyll b; 20, 22 β-Cryptoxanthin;  
21 Chlorophyll a; 23 Echinenone; 24, 26 Astaxanthin mono-ester; 25, 27 Adonixanthin 
mono-ester; 31 α-Carotene; 32, 33, 34 β-Carotene; 37, 39 Astaxanthin di-ester;  
38 Adonixanthin di-ester. 
 
4.3. Carotenoid Biosynthesis 
The biochemical and molecular aspects of carotenoid biosynthesis in higher plants have been well 
elucidated [84], but remain relatively poorly understood in microalgae. However, it is widely accepted 
that microalgae follow a pathway similar to higher plants for the biosynthesis of carotenoids, which 
generally involves five types of reactions (Figure 5): (1) formation of isopentenyl diphosphate (IPP); 
(2) condensation of isoprene units resulting in phytoene, the first C40 carotene; (3) four step-wise 
desaturation reactions converting colorless phytoene to pink-colored lycopene; (4) cyclization of 
lycopene to form β-carotene and α-carotene; and (5) synthesis of xanthophylls by the introduction of 
oxygen groups to carotenes. 
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Figure 5. Schematic diagram of possible carotenoid biosynthesis in microalgae. IPP, 
isopentenyl pyrophosphate; DMAPP, dimethylallyl pyrophosphate; GGPP, geranylgeranyl 
pyrophosphate; PSY, phytoene synthase; PDS, phytoenedesaturase; ZDS, ζ-carotene 
desaturase; CRTISO, carotene isomerase; LCYb, lycopene β-cyclase; LCYe, lycopene  
ε-cyclase; P450b-CHY, cytochrome P450 β-hydroxylase; P450e-CHY, cytochrome P450 
ε-hydroxylase; CHYb, β-carotene hydroxylase; BKT, β-caroteneketolase; ZEP, 
zeaxanthinepoxidase; VDE, violaxanthin de-epoxidase; NXS, neoxanthin synthase; AAT, 
astaxanthin acyl transferase; * denote the genes characterized in C. zofigiensis. 
 
In eukaryotes, IPP is the first intermediate in the carotenoid biosynthetic pathway, which may be 
either assembled from three molecules of acetyl-CoA via mevalonate (mevalonate pathway) or 
condensed from pyruvate and glyceraldehyde phosphate (mevalonate independent pathway).  
C. zofingiensis is thought to synthesize IPP via mevalonate independent pathway as H. pluvialis does; 
however, this remains to be experimentally demonstrated. Sequential addition of three molecules of 
IPP to dimethylallyl-diphosphate (DMAPP), an isoform of IPP, results in the formation of the C20 
compound geranylgeranyl pyrophosphate (GGPP), which is catalyzed by GGPP synthase (GGPPS), 
one member of a closely related family of prenyl transferases (Figure 5). Two GGPP molecules are 
then condensed head-to-head to form phytoene, the first committed step of carotenoid biosynthetic 
pathway, catalyzed by phytoene synthase (PSY) that is regarded as a key rate-limiting enzyme 
controlling the carbon flux into the pathway [85,86]. The PSY gene from C. zofingiensis contains an 
open reading frame (ORF) of 1263 bp that encodes a putative protein of 420 amino acids [85].  
C. zofingiensis PSY harbors three introns and is present as a single copy in the genome [85]. 
Heterologous overexpression of the C. zofingiensis PSY gene in Chlamydomonas reinhardtii can 
enhance the intracellular accumulation of carotenoids [85], which is consistent with previous studies 
overexpressing PSY in algae or higher plants [85–88]. 
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The synthesis of lycopene from phytoene requires four step-wise desaturations, involving two 
structurally and functionally related enzymes phytoene desaturase (PDS) and ζ-carotene desaturase 
(ZDS) (Figure 5). PDS is responsible for the first two desaturation steps resulting in the formation of  
ζ-carotene, which is further desaturated by ZDS to lycopene. PDS from C. zofingiensis has been cloned and 
characterized [89]. The ORF of this gene, interrupted by six introns, encodes a polypeptide of 558 amino 
acid residues; similar to PSY, C. zofingiensis genome contains only a single copy of PDS [89]. There 
are several conserved motifs thought to be important to the desaturation activity of PDS (Figure 6). 
Point mutations in these motifs have been demonstrated to alter, to various extents, the desaturation 
activity of PDSs from Synechococcus pcc7942, H. pluvialis, C. zofingiensis, and C. reinhardtii (Table 1). 
In C. zofingiensis PDS, for example, the mutations of R279P, L399P, V483G, and L516R attenuate the 
desaturation activity by up to 69%. Intriguingly, an L–F change at position 516 enhances the 
desaturation activity by 30%, compared to the 23% decrease caused by the L–R exchange. 
Surrounding the L residue (503–528) is a conserved motif present in PDS polypeptides of higher 
plants, algae and cyanobacteria, which is a proposed carotenoid binding site [90]. The L–F exchange 
may benefit the kinetics of phytoene binding to this enzyme, leading to the enhanced desaturation 
activity. Co-factors are required to facilitate the desaturation activity [91,92]. Therefore, it is also 
possible that the exchange enhances the specific binding of co-factors, contributing to the increased 
PDS activity. PDS is also considered as a rate-limiting enzyme in carotenoid biosynthesis [93]. 
Overexpression of a bacterial phytoene desaturase gene in tobacco [94] and tomato [95], and an 
endogenous PDS gene in H. pluvialis [96], C. reinhardtii [92], and C. zofingiensis [69] have been 
reported to promote carotenoid synthesis. 
Figure 6. Point mutations that affect desaturation activity and norflurazon resistance of 
PDS. C. reinhardtii, Chlamydomonas reinhardtii; C. zofingiensis, Chlorella zofingiensis;  
S. pcc7942, Synechococcus pcc7942, H. pluvialis, Haematococcus pluvialis. Arrows 
indicate the positions of point mutations. 
(503)
(514)
(434)
(502)
(466)
(477)
(397)
(465)
(385)
(396)
(317)
(384)
(261)
(272)
(188)
(260)
C. reinhardtii
C. zofingiensis
S. pcc7942
H. pluvialis
C. reinhardtii
C. zofingiensis
S. pcc7942
H. pluvialis  
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Table 1. The effect of point mutations on PDS desaturation activity and norflurazon resistance. 
Organism Mutation Desaturation Activity (%) 
a
 Norflurazon Resistance 
b
 Reference 
C. zofingiensis 
R279P 
L399P 
V483G 
L516R 
L516F 
32 
94 
81 
67 
133 
18 
14 
17 
28 
31 
[69] 
H. pluvialis L504R <100 43 [96] 
C. reinhardtii 
L505R 
L505F 
80 
128 
24 
29 
[92] 
S. pcc7942 
R195P 
L320P 
V403G 
L436R 
24 
91 
83 
67 
23 
8 
15 
76 
[93] 
a relative in vitro desaturation activity compared to wild type PDS, which is set as 100%; b relative norflurazon resistance 
compared to wild type PDS, which is set as 1. 
Once synthesized, lycopene has two potential destinations; it can be cyclized to α-carotene or  
β-carotene. α-carotene has a β-ring and a ε-ring on each side which differentiates it from β-carotene, 
which harbors two β-rings end groups on both sides. Lycopene β-cyclase is responsible for the 
formation of β-carotene, which has been characterized from C. zofingiensis [97]. β-carotene serves as 
the direct precursor for astaxanthin biosynthesis, via a set of hydroxylation and ketolation steps and 
there are multiple routes it can follow to reach astaxanthin (Figure 5). In H. pluvialis, it is thought that 
β-carotene is converted to canthaxanthin via a two-step ketolation catalyzed by β-carotene ketolase 
(BKT), followed by a further two-step hydroxylation by β-carotene hydroxylase (CHYb) for the 
formation of astaxanthin [63]. In contrast to H. pluvialis, C. zofingiensis seems to employ an alternative 
pathway for astaxanthin biosynthesis. Under astaxanthin induction conditions, C. zofingiensis 
accumulates mainly astaxanthin, followed by adonixanthin, canthaxanthin, and zeaxanthin, and trace 
amount of echinenone and cryptoxanthin (Figure 7). Based on these data, one may infer that 
astaxanthin is synthesized from the ketolation of zeaxanthin instead of the hydroxylation of 
canthaxanthin, which appears unable to be converted to astaxanthin causing it to accumulate as an end 
product. This hypothesis is partially supported by a study using the BKT inhibitor diphenylamine 
(DPA) [98]. When exposing C. zofingiensis to astaxanthin induction conditions, the addition of DPA 
resulted in an increase in the intracellular accumulation of zeaxanthin at the cost of adonixanthin and 
astaxanthin. The further confirmation of this hypothesis, however, requires the support of in vitro assay 
data. C. zofingiensis BKT and CHYb genes have been cloned and characterized [83,99]. Each of the 
two genes is present as a single copy in C. zofingiensis genome. We have recently performed the  
in vitro enzymatic assays of BKT and CHYb and the data indicated that BKT was able to catalyze the 
ketolation of β-carotene to canthaxanthin and of zeaxanthin to astaxanthin, and CHYb showed the 
ability to hydroxylate β-carotene to zeaxanthin but not canthaxanthin to astaxanthin [100], further 
supporting that astaxanthin synthesis in C. zofingiensis is derived from zeaxanthin rather than 
canthaxanthin. Although BKT is capable of converting zeaxanthin to astaxanthin, it has a relatively 
low ketolation activity, causing the accumulation of the intermediate adonixanthin (Figure 7). 
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Astaxanthin is present predominantly in the form of esters in C. zofingiensis [32]. The esterification of 
astaxanthin with fatty acids may need an acyltransferase; however, this acyltransferase has not been 
identified either in C. zofingiensis or in H. pluvialis.  
Figure 7. The relative proportion of carotenoids in C. zofingiensis under astaxanthin 
induction conditions (eight-day induction with 20 g·L
−1
 glucose in the dark). Each carotenoid 
is expressed as percentage of the sum of echinenone, canthaxanthin, adonirubin, 
cryptoxanthin, zeaxanthin, adonixanthin, and astaxanthin, which is set as 100%. Adonirubin 
is not detected.  
 
Although astaxanthin is believed to accumulate in lipid bodies (LBs), the location for synthesis 
remains unclear. It is hypothesized in H. pluvialis that the chloroplast-localized β-carotene serves as an 
intermediate which can cross the plastid membranes towards cytoplasmic LBs where BKT and CHYb 
enzymes are available to convert β-carotene to astaxanthin [82,101]. This membrane-crossing process 
may be mediated by carotenoid-binding proteins instead of the vesicular transport as the latter is not 
observed with ultrastructural studies [101]. The inhibition of de novo fatty acid synthesis is 
accompanied by a drastic decrease in astaxanthin accumulation in H. pluvialis [102]. In contrast,  
C. zofingiensis produces more astaxanthin upon inhibition of the de novo fatty acid synthesis [100]. 
We infer that in C. zofingiensis, unlike in H. pluvialis, the esterification of astaxanthin may not require 
the de novo synthesized fatty acids, but rather, utilizes the fatty acids released from the turnover of 
chloroplast membrane lipids.  
4.4. Factors Affecting Growth and Astaxanthin Production 
Generally, microalgal reproduction requires light, carbon, nitrogen, phosphorus, inorganic salts, 
water, etc. The growth, astaxanthin content and astaxanthin productivity of C. zofingiensis are culture 
condition-dependent and can be greatly influenced by a variety of nutrient and environmental factors. 
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4.4.1. Nutrients 
Carbon is the most prominent element of microalgae that accounts for approximately 50% of the 
microalgal biomass. Carbon dioxide is the primary inorganic carbon source for photosynthesis of  
C. zofingiensis. Under photoautotrophic growth conditions, CO2 concentration has a crucial impact on 
the growth of C. zofingiensis. Too low or too high CO2 is suboptimal for the growth of C. zofingiensis. 
Low CO2 is unable to provide enough carbon to support efficient photosynthesis while high CO2 
causes a pH decrease in the culture medium, which may in turn inhibit the algal growth. Accordingly, 
air enriched with 1%–5% CO2 is provided for the efficient growth of C. zofingiensis. In addition,  
C. zofingiensis is capable of using organic carbon sources such as sugar and acetate. Liu et al. [103] 
investigated the effect of various monosaccharides and disaccharides on growth of C. zofingiensis, and 
the results indicated that glucose, fructose, mannose and sucrose were efficiently consumed by the alga 
for rapid growth whereas lactose and galactose were poorly assimilated and could not support robust 
algal growth. Accordingly, glucose gave rise to the highest astaxanthin content while lactose led to the 
lowest astaxanthin content [13]. Under heterotrophic conditions with glucose as the sole carbon source, 
the cell density and astaxanthin content of C. zofingiensis is associated with the initial glucose 
concentration. Increasing the initial glucose concentration leads to greater final cell densities until the 
glucose is over 30 g·L
−1
 when the increase of glucose concentration causes no significant increase in 
cell density, but rather, decreases the specific growth rate [7,12]. This may suggest that high level of 
sugar somewhat inhibits the algal growth, possibly due to the substrate inhibition, a common issue 
associated with batch cultures. The astaxanthin accumulation in C. zofingiensis is also related to the 
initial glucose concentration and enhanced astaxanthin content is achieved with high glucose 
concentration, e.g., the astaxanthin content at 30 g·L
−1
 glucose is 105% higher than that at 5 g·L
−1
 
glucose [12], possibly due to that high glucose, when assimilated for glycolysis, provides more carbon 
precursors entering the astaxanthin biosynthetic pathway. It is worth noting, however, that further 
increases in sugar concentration fail to enhance astaxanthin level [7,12,104], indicating the presence of 
other limiting factors in addition to carbon precursors.  
Nitrogen is a second important nutrient for algal growth and may account for up to 10% of the algal 
biomass. Commonly used nitrogen sources are in the form of nitrate, urea, and ammonia. Ammonia is 
economically more favorable than the other two nitrogen sources, but it tends to cause a drastic pH 
decrease, especially in unbuffered medium, and may result in severe growth inhibition [105,106].  
In autotrophic cultures, nitrogen is an important factor influencing intracellular accumulation of 
secondary carotenoids, especially astaxanthin, and nitrogen limitation/starvation generally causes the 
enhanced synthesis of astaxanthin in C. zofingiensis [65,81]. However, nutrient limitation/deficiency 
can inhibit algal growth and may even lead to a complete cessation of growth. A prediction of 
astaxanthin content and astaxanthin productivity as affected by nitrogen concentration for C. zofingiensis 
is shown in Figure 8. By manipulating nitrogen concentration, the optimized astaxanthin productivity 
will be achieved in a batch culture. In heterotrophic cultures of C. zofingiensis, nitrogen availability 
plays also a critical role in astaxanthin accumulation. Considering organic carbons are used in 
heterotrophic cultures, carbon/nitrogen (C/N) ratio, controlling the switch between protein and lipid 
synthesis, is usually employed to show the combined effect of carbon and nitrogen on astaxanthin 
synthesis. Thus, it is the higher C/N ratios (corresponding to higher carbon concentrations when the 
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initial nitrogen is fixed or lower nitrogen concentrations when the initial carbon is fixed) that trigger 
the accumulation of astaxanthin. For example, a C/N ratio of 180 gave rise to about one-fold increase in 
astaxanthin content as compared to a C/N ratio of 30 [7]. The increased astaxanthin may likely be due to 
the high C/N ratio providing excess carbon which enters into the carotenoid biosynthetic pathway. 
Figure 8. A schematic view of astaxanthin content and astaxanthin productivity as affected 
by nitrogen concentration for C. zofingiensis. 
 
Phosphorus is a third element required for normal growth of C. zofingiensis. The commonly used 
phosphorus is in a form of phosphate, either as H2PO4
−
 or HPO4
2−
. Phosphorus concentration, 
however, plays a much less prominent role on growth and astaxanthin content of C. zofingiensis than 
nitrogen, which is evident by the fact that phosphate at the range of 0.04–0.33 g·L−1 causes no 
significant change in specific growth rate, final cell density, or astaxanthin content [71]. 
Among the metal ions, iron is an important micronutrient for algal growth. It has been reported that 
iron deficiency caused a severe decrease in C. zofingiensis growth [71]. Iron also plays an important 
role in astaxanthin accumulation. The addition of ferrous ion was found to stimulate carotenogenesis in 
both H. pluvialis and C. zofingiensis for enhanced astaxanthin accumulation [107,108]. This may be 
explained, in part, by the fact that ferrous ion can serve as a generator of hydroxyl radical (·HO) 
through an Fe
2+
-catalyzed Fenton reaction in algal cells, and the accumulation of hydroxyl radical is 
believed to be capable of stimulating astaxanthin synthesis. Besides, ferrous ion is believed to be a 
cofactor for such enzymes as hydroxylases and ketolases involved in the biosynthesis of astaxanthin, 
and its presence may enhance the activity of these enzymes leading to increased astaxanthin  
levels [109]. Other metal ions, e.g., magnesium and manganese, have also been evaluated but are much 
less prominent in affecting astaxanthin synthesis as compared to iron [108].  
4.4.2. Environmental Factors 
Photosynthesis requires light, which is indispensable for the photoautotrophic growth of algae.  
C. zofingiensis shows a typical light intensity-dependent growth. There is a saturation range of light 
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intensity for optimal algal growth, below which the light becomes insufficient, leading to the 
photolimiation-associated slow growth; when exceeding the saturation value, photoinhibition occurs 
and causes growth attenuation or even cell death. It is worth noting that the saturation value may vary 
when different starting cell densities and/or optical light paths are employed. Astaxanthin biosynthesis 
can be greatly affected by light. It has been well studied in H. pluvialis that a high light intensity 
stimulates significantly enhanced astaxanthin accumulation [63,102,110]. Similar to H. pluvialis,  
C. zofingiensis is induced by high light to accumulate astaxanthin [11,65,66,83]. Considering that  
C. zofingiensis is capable of producing astaxanthin in the dark but at much lower rates [12,13], light is 
not necessary for triggering astaxanthin biosynthesis but for enhancing astaxanthin accumulation. The 
underlying mechanism is that high light irradiation produces excess photooxidation that could cause 
the generation of reactive oxygen species (ROS) such as singlet oxygen (
1
O2), superoxide anion (O2
−
), 
and hydroxyl radical (·OH); the antioxidative carotenoids and astaxanthin in particular are produced to 
protect the algal cells against oxidative damages of the ROS. Note that in most studies, high light is not 
deployed alone but accompanied by nitrogen limitation/starvation to induce carotenogenesis for 
astaxanthin accumulation [11,65,66]. These stress conditions, however, cause a severe reduction in 
algal growth and thus a reduction in the final astaxanthin yield of C. zofingiensis. To address the 
decreased growth and astaxanthin content, algal cells are usually cultured with replete nitrogen and a 
growth-favorable light intensity for optimal biomass production, followed by an induction stage with 
the stresses [6]. 
Salinity is another important environmental factor affecting astaxanthin accumulation in algae. Salt 
stress has been demonstrated to induce astaxanthin accumulation in both H. pluvialis and  
C. zofingiensis [11,111]. C. zofingiensis is a freshwater alga with a moderate tolerance of salt up to  
0.1 M NaCl with just a slight impact on algal growth; further increase of salt concentration to 0.2 M 
and 0.4 M, however, reduces significantly the final cell density by 30% and 50%, respectively [11]. 
Nevertheless, addition of 0.2 M salt results in the highest astaxanthin yield, which is 60% higher than 
that of the salt-free cultures [11]. Similarly, Ip [71] reported little difference in cell density with the 
range of 0–0.08 M NaCl. However, the highest astaxanthin yield was achieved with 0.08 M NaCl; 
further increase of salt concentration caused severe decrease of the yield [71]. This difference may be 
explained by the different culture conditions used in these two studies.  
Ip [71] also studied the effects of culture temperature and medium pH on growth and astaxanthin 
accumulation in C. zofingiensis. The alga grows well at the culture temperature of 20–30 °C and the 
optimal temperature for astaxanthin accumulation is between 25 and 30 °C. C. zofingiensis is capable 
of tolerating a relative wide range of pH (5.5–8.5) and the pH 5.5 gives rise to the highest astaxanthin 
content and astaxanthin yield. In addition, astaxanthin accumulation is enhanced by external 
supplementation of the culture medium with ROS such as hydrogen peroxide, or reactive nitrogen 
species/reactive nitrogen intermediates (RNS/RNI) such as peroxynitrite and nitryl chloride, or by the 
endogenous arousal of oxidative stresses via inhibition of intracellular antioxidative enzymes.  
4.4.3. Molecular Mechanism of Astaxanthin Biosynthesis 
In C. zofingiensis, astaxanthin biosynthesis is believed to be regulated, at least in part, at the 
transcriptional level, as the mRNA level of carotenogenic genes is well coordinated with the 
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intracellular content of astaxanthin. For instance, high light triggers the up-regulation of CHYb and 
BKT, and accordingly enhances the biosynthesis of zeaxanthin, canthaxanthin, and astaxanthin; while 
salinity stress up-regulates the expression of BKT only and thus promotes the biosynthesis of 
canthaxanthin and astaxanthin [83]. However, the 24–48 h delay between up-regulation of carotenogenic 
genes and the accumulation of astaxanthin indicate that they are not tightly coordinated and suggest 
that factors other than transcriptional control are involved in carotenoid biosynthesis. High light and 
salinity stresses stimulate the generation of ROS of different kinds, which may serve as the messenger 
molecule to trigger the expression of specific carotenogenic genes for enhanced astaxanthin 
accumulation. It is commonly perceived that the formation of astaxanthin is a survival strategy of the 
algae under photooxidative stress and other adverse conditions. Astaxanthin biosynthesis may offer 
multiple roles in protecting C. zofingiensis cells from those oxidative stresses (Figure 9), including  
(1) the accumulation of astaxanthin in cytoplasmic lipid bodies functioning as a ―sunscreen‖ to reduce 
the amount of light impinging on chloroplast for attenuated photosynthetic photoinhibition and 
photodamage caused by excess photons; (2) lowering subcellular oxygen levels by forming oxygen-rich 
astaxanthin molecules; (3) converting photosynthetically evolved molecular oxygen into water via a 
concerted electron transport from carotenogenic desaturation steps through the photosynthetic 
plastoquinone pool (PQ) to plastid terminal oxidase (PTOX); (4) astaxanthin serving as an antioxidant 
to scavenge the generated ROS.  
Figure 9. Illustration of the multiple roles of astaxanthin biosynthesis in protecting  
C. zofingiensis from photooxidative stress. 
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4.5. Mass Cultivation 
C. zofingiensis is capable of growing autotrophically, mixotrophically, and heterotrophically. 
Generally, the mass cultivation of C. zofingiensis involves open systems, closed photobioreactors 
Mar. Drugs 2014, 12 3502 
 
(PBRs), or fermenters. The Chlorella outdoor cultivation can be traced back to late 1940s with United 
States, Germany, and Japan launching cultivation processes almost concurrently. Circular pond is one 
of the most widely used open systems for Chlorella mass cultivation, and is reasonably scalable by 
increasing the pond diameter up to 50 m [112]. Raceway pond is another popular open culture system 
for Chlorella cultures. The ponds are usually maintained with cultures at a depth of less than 30 cm, 
aiming to facilitate the sunlight penetration to the bottom of the cultures [113]. Although both circular 
and raceway ponds are easy to construct and maintain in low cost, their drawback is that they can 
produce only very low cell densities (commonly less than 1 g cell dry weight per liter). Another open 
system, but rarely used, is the inclined thin layer cascade developed by Czech researchers [114]. This 
system characterizes itself by a thin layer of culture suspension, great flow turbulence, and high ratio 
of light-exposed surface area to volume, which together enable a high volumetric biomass yield  
(e.g., up to 40 g·L
−1
). This system may be more suitable than the circular and raceway ponds for 
growing C. zofingiensis for astaxanthin production, as it can provide a short light path and thus bestow 
excessive photons per cell to help induce astaxanthin accumulation. Nevertheless, the open systems 
possess intrinsic disadvantages such as rapid water loss, ease of contamination, and difficulty in 
controlling the cultures.  
Closed photobioreactors (PBRs) can address the problems associated with the open systems.  
PBRs are made of transparent materials with a large surface area/volume ratio. Popular PBRs include 
tubular [113] and panel styles [115]. Feng et al. [14] tried to grow C. zofingiensis outdoors in panel 
PBRs, but achieved only a low volumetric biomass productivity, most likely due to the long light path 
of the PBRs. We deployed panel PBRs with various light paths and showed that the length of light path 
is critical to the biomass production of C. zofingiensis [116]. Within the light path range of 2–20 cm, the 
C. zofingiensis biomass productivity increases as the light path shortens, up to 1.2 g·L
−1
·day
−1
 
(achieved with the light path of 2 cm); the short light path also benefits the accumulation of 
astaxanthin but this system requires high initial cell densities to minimize or eliminate photoinhibition. 
In this context, C. zofingiensis is first inoculated in panel PBRs with long light paths at low cell density 
to generate biomass. High-concentration cell cultures are then transferred to thin PBRs for continuing 
biomass production and astaxanthin accumulation.  
C. zofingiensis can also grow well heterotrophically in fermenters [13,117]. Conventionally, 
fermenters are used for culturing non-photosynthetic organisms such as bacteria, yeasts, and animal 
cells. The well-developed fermenter technologies enable better control of C. zofingiensis growth for 
astaxanthin production. Generally, in a heterotrophic batch culture, a high initial concentration of 
substrates (e.g., glucose) is used to provide sufficient carbon for achieving a high cell density. 
However, the use of a high substrate concentration usually causes growth inhibition. For instance, a sugar 
concentration of over 30 g·L
−1
 inhibits the growth of C. zofingiensis [12,117]. The substrate-associated 
inhibition causes a decrease not only in the specific growth rate but also in the biomass yield 
coefficient based on sugars [13,117], thereby leading to increased cost inputs. To this end, a fed-batch 
cultivation strategy is deployed, which involves the stepwise addition of substrate to maintain algal cell 
growth with minimized inhibition. There have been several reports mentioning fed-batch cultivation  
of C. zofingiensis for astaxanthin production in which astaxanthin yield could reach up to  
56 mg·L
−1
 [7,13,117]. Although the adoption of fed-batch culture strategy proves to be able to 
eliminate substrate-based inhibition, it is unable to overcome the inhibition caused by the toxic 
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metabolites that are produced by the algal cultures and accumulate as the cells build up. To address 
this, other strategies may be applied, such as continuous cultivation with or without cell recycling. 
Continuous cultivation refers to the continuous addition of fresh medium with simultaneous removal of 
products to maintain a constant culture volume [118]. Figure 10A shows the schematic diagram of a 
continuous cultivation system. This system is capable of effectively eliminating metabolite-based 
inhibition but is accompanied by a drop in final cell density as well as sugar utilization efficiency.  
In contrast, continuous cultivation with cell recycling, known as perfusion culture, is a culture 
technique combining the advantages of both fed-batch and continuous culture system. Perfusion 
minimizes the inhibition associated with both high substrate concentration and buildup of toxic 
metabolites to maintain high cell density and productivity [119]. As illustrated by Figure 10B, in a 
perfusion culture system, the algal cells are retained by a retention device, whereas the spent medium 
(cell-free) is removed from the fermenter, with the simultaneous feeding of fresh medium to maintain 
sufficient nutrient supply. Though the intracellular astaxanthin content is significantly lower than that of 
photoautotrophic growth, heterotrophic growth offers much higher cell density and biomass productivity, 
thus giving rise to greater astaxanthin yield and astaxanthin productivity as well [7,13,66].  
Figure 10. Schematic diagram of the continuous (A) and perfusion (B) fermenter culture 
systems. X, cell concentration; V, culture volume; S, carbon concentration in medium;  
F, flow rate of feed; F1, flow rate of perfusion; S0, carbon concentration in feed. The flow 
rates are controlled to maintain the culture volume constant. 
Spent medium
F1, S
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Table 2. Production of biomass and astaxanthin by C. zofingiensis and other organisms. 
Strain Culture Conditions 
a
 
Cell Density 
(g·L
−1
) 
Biomass Productivity 
(g·L
−1
·day
−1
) 
Astaxanthin Content 
(mg·g
−1
 Dry Weight) 
Astaxanthin 
Yield (mg·L
−1
) 
Astaxanthin Productivity 
(mg·L
−1
·day
−1
) 
References 
C. zofingiensis        
CCAP211/14 P, batch 6.7 0.74 3.7 24.8 2.8 [11] 
SAG211/14 P, batch - - 6.5 - 0.8 [66] 
ATCC30412 M, batch 9.5 - 1.3 12.5 - [104] 
ATCC30412 H, batch 10.2 - 1.0 10.3 - [12] 
ATCC30412 H, fed-batch 53 3.5 0.69 32.4 2.2 [13] 
ATCC30412 H, batch 12.9 1.6 1.18 13.6 1.7 [117] 
ATCC30412 
H, batch 
H, fed-batch 
10.3 
45.6 
2.1 
4.7 
1.31 
1.19 
13.5 
56.1 
2.3 
5.6 
[7] 
H. pluvialis        
CCAP34/7 P, batch 1.6 0.02 27 43.2 0.44 [111] 
UTEX16 
M, batch 
M, fed-batch 
2.65 
2.74 
0.13 
0.14 
20.1 
23.5 
53.4 
64.4 
2.6 
3.2 
[6] 
CCAP34/7 P, batch - - 22.7 - 2.7 [66] 
CCAP34/8 P, batch 7.0 0.41 11.0 77 4.4 [120] 
CCAP34/8 P, continuous - 0.6 8 - 5.6 [121] 
NIES-144 P, fed-batch 6.7 0.2 36 390 7.2 [122] 
CCAP34/8 P, continuous 1.5 0.7 10 15 7 [123] 
X. dendrorhous        
ATCC24202 H, fed-batch 30 5.1 0.72 21.6 3.7 [124] 
NRRL Y17268 H, Batch 23.2 3.4 0.45 10.4 1.5 [125] 
ATCC24202 H, fed-batch 18.8 4.7 0.3 5.7 1.4 [126] 
2A2N b H, batch 36 7.2 1.1 39.6 7.9 [127] 
ZJUT46 b 
H, batch 
H, fed-batch 
15.7 
17.7 
2.85 
3.2 
1.74 
2.0 
27.1 
34.4 
5.0 
6.4 
[128] 
[129] 
E5042 b H, batch 30.7 5.4 2.5 76.8 13.5 [130] 
VKPM Y2476 b M, fed-batch 88 9.7 4.7 420 45.6 [131] 
a P, photoautrophic, M, mixotrophic, H, heterotrophic; b mutants.  
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4.6. Comparison of Astaxanthin Production from C. zofingiensis and Other Organisms 
The green microalgae H. pluvialis and C. zofingiensis, and the yeast X. dendrorhous are the most 
studied microorganisms for astaxanthin production. In general, microbe-based astaxanthin production 
pipeline involves a set of processes: astaxanthin-rich biomass production, harvest, drying, cell 
disruption and astaxanthin extraction, and concentration and purification if necessary. Astaxanthin 
content is a key factor to access the suitability of astaxanthin production from a selected organism, and 
higher astaxanthin content is considered more cost favorable for downstream process. In this context, 
among the three organisms, H. pluvialis has been the first choice as a source for natural astaxanthin, 
followed by C. zofingiensis and X. dendrorhous, as H. pluvialis has the highest intracellular 
astaxanthin content that may reach up to 3.6% of dry weight (Table 2). X. dendrorhous possesses the 
lowest level of astaxanthin, which is commonly below 0.1% of cell dry weight; it is worth mentioning, 
however, that some X. dendrorhous mutants can accumulate significantly more astaxanthin than the 
wild type ones (Table 2). Biomass density is also an important factor and high density helps to lower 
the harvest cost, which may contribute up to 30% of the overall cost depending on the organism used 
and the biomass concentration. H. pluvialis grows slowly and achieves only a low cell density  
(e.g., up to 7 g·L
−1
); in contrast, C. zofingiensis grows fast and can build up an ultrahigh cell density 
(with a potential of up to 100 g·L
−1
), thereby greatly lowering the harvest cost as compared to  
H. pluvialis. With the high cell density, the volumetric astaxanthin yield and productivity of  
C. zofingiensis are comparable to that of H. pluvialis (Table 2). What is more, unlike H. pluvialis or  
X. dendrorhous, C. zofingiensis is capable of growing robustly under both heterotrophic (high cell 
density) and photoautotrophic (enhanced astaxanthin content) conditions, which may warrant further 
exploration of this alga for astaxanthin production.  
5. Possible Improvements in C. zofingiensis Astaxanthin Production Economics 
C. zofingiensis has shown great potential as an alternative source of astaxanthin, and the astaxanthin 
production economics of C. zofingiensis can be further improved by strain improvement via genetic 
engineering, development of next generation culture systems, and the establishment of biorefinery 
production strategies.  
The relatively low intracellular astaxanthin content is a key issue contributing to the relatively high 
production cost of C. zofingiensis astaxanthin. Mutagenesis has been demonstrated as an effective 
approach to enhancing the biosynthesis of carotenoids for elevated astaxanthin accumulation in  
H. pluvialis [68,132]. Recently, enhanced astaxanthin content has also been achieved in C. zofingiensis by 
mutagenesis [133]. Comprehensive screening with further mutagenesis may produce mutants with 
even higher astaxanthin content. Compared to the time-consuming mutagenesis methods, direct genetic 
engineering of the astaxanthin pathway appears to be a more feasible and efficient approach to 
increasing the intracellular astaxanthin accumulation in C. zofingiensis. As indicated by Figure 7,  
in C. zofingiensis, astaxanthin accounts for ca. 50% of total keto-carotenoids with the other 50% 
mostly adonixanthin and canthaxanthin. This limits its use for humans as such mixtures are not 
approved in the USA, Europe or Australia either for health foods, functional foods or other 
applications such as food coloring. A purification process, which is challenging and adds cost to 
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astaxanthin production, is therefore needed, making C. zofingiensis currently less favorable. 
Considering that the C. zofingiensis CHYb cannot accept canthaxanthin as the substrate to produce 
astaxanthin and the BKT has a relatively low activity for catalyzing the formation of astaxanthin from 
adonixanthin, manipulating the specific astaxanthin biosynthetic steps should largely promote the 
percentage of astaxanthin (purity) and enhance the astaxanthin production on a per cell basis (content). 
This engineering of astaxanthin production could be achieved by introducing a CHYb that can convert 
canthaxanthin to astaxanthin and a BKT that can catalyze the efficient conversion of adonixanthin to 
astaxanthin using an efficient and stable transformation system for C. zofingiensis recently developed [69].  
Photobioreactors are believed to be a promising system for photoautotrophic mass cultivation of  
C. zofigniensis. However, there are many issues associated with the current PBR system, such as 
relatively poor light availability and poor mixing when scaling up, buildup of dissolved oxygen, large 
dark volumes, and the intensive capital required for construction and maintenance. The development of 
next generation PBR systems addressing the above mentioned drawbacks will have great potential to 
improve the production economics. Furthermore, PBRs can be coupled with fermenters for growing  
C. zofingiensis and astaxanthin production. A sophisticated fermenter system bestows great advantages 
for biomass production of C. zofingiensis, but the intracellular astaxanthin content in this system needs 
to be improved. For instance, the maximal astaxanthin content achieved in heterotrophic cultures is 
below 2 mg·g
−1
, while in autotrophic cultures provided with high light, the astaxanthin can reach up  
to 6 mg·g
−1
 [7,11,13,66], indicating that light is a key factor for astaxanthin induction and 
accumulation. In this context, we propose a heterotrophic-phototrophic two-stage culture strategy to 
grow C. zofingiensis to improve production of astaxanthin: C. zofingiensis is first cultured heterotrophically 
in fermenters for rapid accumulation of biomass which is then transferred to PBRs with high light 
conditions for the induction of astaxanthin. The proposed culture strategy combines the advantages of 
both heterotrophic and phototrophic modes and eliminates the possible contamination associated with 
mixotrophic growth, and can enhance astaxanthin production by three-fold [116]. This may open a 
door to substituting the currently used heterotrophic culture method for scale-up toward possible 
commercial production of astaxanthin by C. zofingiensis.  
C. zofingiensis also produces substantial amounts of lipids, carbohydrates, and proteins. From a 
biorefinery perspective, the lipids are suitable for biofuels production and the residual biomass after 
lipid extraction can be potentially used as nutraceuticals and animal feeds. In addition, the 
carbohydrates may be utilized to produce methane by anaerobic digestion. The integrated production 
of astaxanthin, oil, and other products, coupled with the possible recycling of water and nutrients, 
represents a potential and promising strategy toward further improving C. zofingiensis astaxanthin 
production economics.  
6. Conclusions  
Microalgae represent a promising source of natural astaxanthin that can potentially replace the 
chemically synthesized astaxanthin. C. zofingiensis, a possible alternative producer for astaxanthin, has 
been intensively investigated in recent years. To date, substantial achievements have allowed better 
understanding of astaxanthin biosynthesis in C. zofingiensis and should soon allow utilization of this 
alga for astaxanthin production. Future exploration of using C. zofingiensis for astaxanthin production 
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may lie in genetic engineering of this alga for enhanced biosynthesis of astaxanthin (to increase 
astaxanthin content and purity), development of next generation culture systems for sustainable and 
cost-effective production of astaxanthin-rich biomass, and exploration of state-of-art biorefinery-based 
integrated production strategies. Advances occurring in these areas will greatly expand the production 
capacity and lower the production cost, allowing C. zofingiensis to be a competitive source of natural 
astaxanthin. To this end, ―omics‖ analyses (genomics, transcriptomics, and proteomics) of C. zofingiensis 
are currently underway, which will benefit the understanding of astaxanthin biosynthesis and 
development of a new molecular toolbox for more efficient manipulation of the production strain toward 
economically feasible production of astaxanthin. 
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